<i>ADAR</i> Expression and Single Nucleotide Variants in Multiple Sclerosis Patients Affect the Response to Interferon Beta Therapy

<i>ADAR</i> Expression and Single Nucleotide Variants in Multiple Sclerosis Patients Affect the Response to Interferon Beta Therapy

Interferon (IFN)-β is the first-line disease management choice in multiple sclerosis (MS) with profound effects; however, in up to 50% of patients, clinical response does not occur. Ascertaining the responding state, need a long-term clinical follow-up, and this may lead to delay in use of other eff...

Full description

Bibliographic Details
Main Authors: Fakhr Fakhr, Shaygannejad Shaygannejad, Khorrami Khorrami, Saberi Saberi, Mirmosayyeb Mirmosayyeb, Sadeghi Sadeghi, Kheirollahi Kheirollahi
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2023-09-01
Series:Global Medical Genetics
Subjects:
multiple sclerosis
interferon-β
ADAR
rs2229857
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1771001

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1771001

Similar Items